Lepping, P, Harborne, GC. Polypharmacy: how bad are we really?
2010; 34: 208–9.
Centorrino, F, Eakin, M, Bahk, WM, Kelleher, JP, Goren, J, Salvatore, P, et al. In-patient antipsychotic drug use in 1998, 1993 and 1989. Am J Psychiatry
2002; 159: 1932–5.
Gilmer, TP, Dolder, CR, Folsom, DP, Mastin, W, Jeste, DV. Antipsychotic polypharmacy trends among medical beneficiaries with schizophrenia in San Diego County, 1999–2004. Psychiatr Serv
2007; 58: 1007–10.
Tungaraza, TE, Gupta, S, Jones, J, Poole, R, Slegg, G.
Polypharmacy and high-dose antipsychotic regimes in the community. Psychiatrist
2010; 34: 44–6.
Ranceva, N, Ashraf, W, Odelola, D.
Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines. J Clin Pharmacol
2010; 50: 699–704.
Langan, J, Shajahan, P.
Antipsychotic polypharmacy: review of mechanisms, mortality and management. Psychiatrist
2010; 34: 58–62.